Search research articles
Contact Us
Filters
Showing results (1-10 of 378) with videos related to
Page
of 38
Sort By:
Clinical Advances in Hematology & Oncology : H&O
|
September 17, 2005
COX-2 inhibitors and hypercoagulability
Michael E Farkouh
JACC. Cardiovascular Interventions
|
May 23, 2015
Blood glucose variability: a new metric for interventional cardiology?
Michael E Farkouh
Annals of Internal Medicine
|
February 22, 2012
ACP Journal Club. High-sensitivity troponin < 3 ng/L ruled out acute myocardial infarction
Michael E Farkouh
Trends in Cardiovascular Medicine
|
September 26, 2015
Non-steroidal anti-inflammatory drugs and cardiovascular risk: At crossroads
Michael E Farkouh
Journal of the American College of Cardiology
|
September 6, 2014
Primary prevention of atherosclerotic cardiovascular disease: bringing clinicians and patients to the starting line
Michael E Farkouh
JACC. Cardiovascular Interventions
|
February 19, 2018
Moving Beyond the Stent: Identifying the Percutaneous Coronary Intervention Patient With Silent Diabetes and Pre-Diabetes
Michael E Farkouh
Nature Clinical Practice. Cardiovascular Medicine
|
January 31, 2007
How important is screening angiography for CAS in diabetic patients awaiting transplant? A cardiologist's view
Michael E Farkouh
Annals of Internal Medicine
|
January 28, 2009
ACP Journal Club. Aspirin and/or antioxidants did not prevent CV events in diabetes and peripheral arterial disease
Michael E Farkouh
Evidence-Based Medicine
|
October 2, 2009
Screening for CAD in asymptomatic patients with type 2 diabetes did not reduce risk of cardiac events
Michael E Farkouh
Polskie Archiwum Medycyny Wewnetrznej
|
October 3, 2013
Getting to the heart of the matter: a trialist's approach to the use of nonsteroidal anti‑inflammatory drugs for patients with chronic pain syndromes
Michael E Farkouh
Page
of 38
Search research articles
Search
Showing results (1-10 of 378) with videos related to
Sort By:
Page
of 38
Clinical Advances in Hematology & Oncology : H&O
|
September 17, 2005
COX-2 inhibitors and hypercoagulability
Michael E Farkouh
JACC. Cardiovascular Interventions
|
May 23, 2015
Blood glucose variability: a new metric for interventional cardiology?
Michael E Farkouh
Annals of Internal Medicine
|
February 22, 2012
ACP Journal Club. High-sensitivity troponin < 3 ng/L ruled out acute myocardial infarction
Michael E Farkouh
Trends in Cardiovascular Medicine
|
September 26, 2015
Non-steroidal anti-inflammatory drugs and cardiovascular risk: At crossroads
Michael E Farkouh
Journal of the American College of Cardiology
|
September 6, 2014
Primary prevention of atherosclerotic cardiovascular disease: bringing clinicians and patients to the starting line
Michael E Farkouh
JACC. Cardiovascular Interventions
|
February 19, 2018
Moving Beyond the Stent: Identifying the Percutaneous Coronary Intervention Patient With Silent Diabetes and Pre-Diabetes
Michael E Farkouh
Nature Clinical Practice. Cardiovascular Medicine
|
January 31, 2007
How important is screening angiography for CAS in diabetic patients awaiting transplant? A cardiologist's view
Michael E Farkouh
Annals of Internal Medicine
|
January 28, 2009
ACP Journal Club. Aspirin and/or antioxidants did not prevent CV events in diabetes and peripheral arterial disease
Michael E Farkouh
Evidence-Based Medicine
|
October 2, 2009
Screening for CAD in asymptomatic patients with type 2 diabetes did not reduce risk of cardiac events
Michael E Farkouh
Polskie Archiwum Medycyny Wewnetrznej
|
October 3, 2013
Getting to the heart of the matter: a trialist's approach to the use of nonsteroidal anti‑inflammatory drugs for patients with chronic pain syndromes
Michael E Farkouh
Page
of 38